Biohaven Pharmaceutical Holding Co Ltd (BHVN) Stock Analysis

Biohaven Pharmaceutical Holding Co Ltd (BHVN) is a publicly traded company in the HEALTHCARE sector. It trades at $10.12, carries a market capitalization of $1.72B. This page summarizes the public market data, fundamentals, and frequently asked questions for BHVN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE

Key Metrics

Market Sentiment

Biohaven Pharmaceutical Holding Co Ltd currently has a Bullish sentiment score of 0.39.

About Biohaven Pharmaceutical Holding Co Ltd

Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical innovator headquartered in New Haven, Connecticut, specializing in the development of transformative therapies for neurological diseases and rare disorders. The company harnesses its advanced research and development capabilities to deliver promising product candidates that aim to address significant unmet medical needs in the U.S. market. With a strong emphasis on scientific rigor and a commitment to patient-centric solution...

GNG Research Analysis

GNG Research scores Biohaven Pharmaceutical Holding Co Ltd (BHVN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BHVN.

Frequently Asked Questions

Does BHVN pay dividends?

Biohaven Pharmaceutical Holding Co Ltd (BHVN) does not currently pay a regular dividend.

What is BHVN's market cap?

Biohaven Pharmaceutical Holding Co Ltd (BHVN) has a market capitalization of $1.72B with a current stock price of $10.12.